UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 80

Sortiert nach

S37 Characteristics of breast cancer patients unlikely to benefit from adjuvant therapy

Breast (Edinburgh), 2011, Vol.20, p.S14-S14

2011

Volltextzugriff (PDF)

Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies

Annals of oncology, 2007-03, Vol.18 (3), p.546-550

2007

Volltextzugriff (PDF)

Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients

European journal of cancer (1990), 2002-12, Vol.38 (18), p.2397-2406

2002

Volltextzugriff (PDF)

Improved outcome from substituting methotrexate with epirubicin: Results from a randomised comparison of CMF versus CEF in patients with primary breast cancer

European journal of cancer (1990), 2007-03, Vol.43 (5), p.877-884

2007

Volltextzugriff (PDF)

The present state of the art in chemotherapy for soft tissue sarcomas in adults: the EORTC point of view

Critical reviews in oncology/hematology, 1995-10, Vol.20 (3), p.193-201

1995

Volltextzugriff (PDF)

Grading of soft tissue sarcomas: Experience of the EORTC soft tissue and bone sarcoma group

European journal of cancer (1990), 1993, Vol.29 (15), p.2089-2093

1993

Volltextzugriff (PDF)

Decreased efficacy of cyclophosphamide, epirubicin and 5-fluorouracil in metastatic breast cancer when reducing treatment duration from 18 to 6 months

European journal of cancer (1990), 1993, Vol.29 (4), p.527-531

1993

Volltextzugriff (PDF)

Reduced mortality for women with mammography-detected breast cancer in east Denmark and south Sweden

European journal of cancer (1990), 2006-11, Vol.42 (16), p.2773-2780

2006

Volltextzugriff (PDF)

S42 Scandinavian/nordic adjuvant trials in breast cancer

European journal of cancer (1990), 1998-02, Vol.34, p.S10-S10

Mouridsen, H.T.

1998

Volltextzugriff (PDF)

Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables?—A population-based study

European journal of cancer (1990), 2004-05, Vol.40 (8), p.1233-1243

2004

Volltextzugriff (PDF)

Incidence of New Primary Cancers After Adjuvant Tamoxifen Therapy and Radiotherapy for Early Breast Cancer

JNCI : Journal of the National Cancer Institute, 1991-07, Vol.83 (14), p.1013-1017

1991

Volltextzugriff (PDF)

BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age

Journal of medical genetics, 2001-06, Vol.38 (6), p.361-368

2001

Volltextzugriff (PDF)

402 Adjuvant endocrine therapy in pre- and postmenopausal women with primary breast cancer. A 25-year report of the Copenhagen breast cancer trials

European journal of cancer supplements, 2003-09, Vol.1 (5), p.S123-S123

2003

Volltextzugriff (PDF)

Systemic therapy of advanced breast cancer

Drugs (New York, N.Y.), 1992, Vol.44 Suppl 4 (Supplement 4), p.17-28

Mouridsen, H T

1992

Volltextzugriff (PDF)

Comment on “Anastrozole (Arimidex ™) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results” by J.-M. Nabholtz et al

European journal of cancer (1990), 2004-05, Vol.40 (7), p.1095-1096

2004

Volltextzugriff (PDF)

Chairman's introduction

European journal of cancer supplements, 2003, Vol.1 (6), p.263-264

Mouridsen, H.T.

2003

Volltextzugriff (PDF)

Immunoassays of urokinase (uPA) and its type-1 inhibitor (PAI-1) in detergent extracts of breast cancer tissue

European journal of cancer (1990), 2003-05, Vol.39 (7), p.899-908

2003

Volltextzugriff (PDF)

Adjuvant systemic therapy in breast cancer

European journal of cancer (1990), 1993, Vol.29, p.S12-S12

Mouridsen, H.T.

1993

Volltextzugriff (PDF)

Is breast conserving surgery a risk factor in young breast cancer patients?

European journal of cancer (1990), 2001-04, Vol.37, p.S269-S269

2001

Volltextzugriff (PDF)

Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer—a randomised study with more than 10 years follow-up from the danish breast cancer cooperative group

European journal of cancer (1990), 1999-01, Vol.35 (1), p.39-46

1999

Volltextzugriff (PDF)

Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer

European journal of cancer (1990), 1995, Vol.31 (13), p.2289-2295

1995

Volltextzugriff (PDF)

High-dose DTIC in advanced soft-tissue sarcomas in the adult

Annals of oncology, 1991-04, Vol.2 (4), p.307-309

1991

Volltextzugriff (PDF)

Risk of late stage breast cancer following a childbirth

European journal of cancer (1990), 1999-09, Vol.35, p.S274-S274

1999

Volltextzugriff (PDF)

Combined epirubicin and vinorelbine as first-line therapy in metastatic breast cancer: a pilot study performed by the Danish Breast Cancer Cooperative Group

Breast (Edinburgh), 2003-02, Vol.12 (1), p.42-50

2003

Volltextzugriff (PDF)

PP-6-20 Survival Following First Episode of Hypercalcaemia in Breast Cancer Patients

European journal of cancer (1990), 1996, Vol.32, p.41-42

1996

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(77)
Buchkapitel
(3)

Sprache

Englisch
(80)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

S37 Characteristics of breast cancer patients unlikely to benefit from adjuvant therapy

Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies

Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients

Improved outcome from substituting methotrexate with epirubicin: Results from a randomised comparison of CMF versus CEF in patients with primary breast cancer

The present state of the art in chemotherapy for soft tissue sarcomas in adults: the EORTC point of view

Grading of soft tissue sarcomas: Experience of the EORTC soft tissue and bone sarcoma group

Decreased efficacy of cyclophosphamide, epirubicin and 5-fluorouracil in metastatic breast cancer when reducing treatment duration from 18 to 6 months

Reduced mortality for women with mammography-detected breast cancer in east Denmark and south Sweden

S42 Scandinavian/nordic adjuvant trials in breast cancer

Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables?—A population-based study

Incidence of New Primary Cancers After Adjuvant Tamoxifen Therapy and Radiotherapy for Early Breast Cancer

BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age

402 Adjuvant endocrine therapy in pre- and postmenopausal women with primary breast cancer. A 25-year report of the Copenhagen breast cancer trials

Systemic therapy of advanced breast cancer

Comment on “Anastrozole (Arimidex ™) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results” by J.-M. Nabholtz et al

Chairman's introduction

Immunoassays of urokinase (uPA) and its type-1 inhibitor (PAI-1) in detergent extracts of breast cancer tissue

Adjuvant systemic therapy in breast cancer

Is breast conserving surgery a risk factor in young breast cancer patients?

Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer—a randomised study with more than 10 years follow-up from the danish breast cancer cooperative group

Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer

High-dose DTIC in advanced soft-tissue sarcomas in the adult

Risk of late stage breast cancer following a childbirth

Combined epirubicin and vinorelbine as first-line therapy in metastatic breast cancer: a pilot study performed by the Danish Breast Cancer Cooperative Group

PP-6-20 Survival Following First Episode of Hypercalcaemia in Breast Cancer Patients

Suchergebnisse filtern